Profit (Loss) (72.28) 42.70 (114.98) (269.26) Earnings per share (Baht per share) (0.02) 0.01 (0.03) (269.26) Net Profit The company and subsidiaries realized net loss of Year 2017 ended as of December 31

) Net Profit (Loss) (72.28) 42.70 (114.98) (269.26) Earnings per share (Baht per share) (0.02) 0.01 (0.03) (269.26) Net Profit The company and subsidiaries realized net loss of Year 2017 ended as of

market was strong as the sugar season was prolonged and infrastructure projects supported our key markets of steel and construction. The Thai economy continues to outperform expectations and while we

Capital Market Supervisory Board No. TorChor. 34/2551 Re: Application for and Approval of Offer for Sale of Newly Issued Share Warrants and Newly Issued Underlying Shares ------------------------------ By

11,638.0 (198.0) (1.7%) Normalized Net Profit/3 2,864.7 2,917.9 53.2 1.9% /1 Including other income and share of profit from investments in associates and JVs /2 Gross profit including share of profit from

Net Profit/3 604.5 340.6 (263.8) (43.6%) /1 Including other income and share of profit from investments in associates and JVs /2 Gross profit including share of profit from investments in associates and

- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager

after capital increase : 5,000,000 HKD  No. of shares purchased : 3,300 Ordinary shares  Price per share : HKD 100 per 1 Ordinary shares  Total value of the transaction : HKD 330,000 or Baht 1,421,805

. Analysis of Cost and Expenses 1. In Q2 2017, Cost of sales was 3,632 MTHB, increased by 127 MTHB comparing to 2016 or 3.6% due to the increase of sales volumes and higher Glycerin costs from tight market

per share Guarantee amount provided by the company : Previous HKD 1,500,000.- New HKD 500,000.- (7) General description of connected transaction Type of transaction : Transaction regarding grant of